Literature DB >> 22563204

Lymphomatoidgastropathy mimicking extranodal NK/T cell lymphoma, nasal type: a case report.

Tomohiro Terai1, Mitsushige Sugimoto, Hiroki Uozaki, Tetsushi Kitagawa, Mana Kinoshita, Satoshi Baba, Takanori Yamada, Satoshi Osawa, Ken Sugimoto.   

Abstract

Extranodal natural killer (NK)/T-cell lymphoma, nasal type, exhibits aggressive tumor behavior and carries a poor prognosis. Recently, lymphomatoid gastropathy with NK/T cell infiltration into gastric mucosa has been recognized as a pseudo-malignant disease which regresses without treatment. Because the conventional immunohistochemical criteria of lymphomatoid gastropathy is similar to that of extranodal NK/T-cell lymphoma nasal type, it is difficult to distinguish between the two conditions by histopathological evaluation only. Here, we report a rare case of lymphomatoid gastropathy in a 57-year-old female. Gastroendoscopy on routine check-up revealed elevated reddish lesions < 1 cm in diameter in the gastric fornix and body. Although repeat endoscopies at 1 and 6 mo later revealed no gastric lesions at any locations without any treatments, at 12 mo later gastric lymphomatoid lesions recurred at gastric fornix and body. Histological examination of endoscopic biopsy specimens at 12 mo showed atypical NK cell infiltration with CD3⁺, CD4⁻, CD5⁻, CD7⁺, CD8⁻, CD20⁻, CD30⁻, CD56⁺, CD79a⁻ and T-cell-restricted intracellular antigen-1⁺ into gastric mucosa. After treatment for Helicobacter pylori (H. pylori) eradication, the lesions disappeared in all locations of the gastric fornix and body over the subsequent 12 mo. Here, we report a case of H. pylori-positive lymphomatoid gastropathy with massive NK-cell proliferation, and also review the literature concerning newly identified lymphomatoid gastropathy based on comparison of extra nodal NK/T-cell lymphoma nasal type. In any case, these lesions are evaluated with biopsy specimens, the possibility of this benign entity should be considered, and excessive treatment should be carefully avoided. Close follow-up for this case of lymphomatoid gastropathy is necessary to exclude any underlying malignancy.

Entities:  

Keywords:  Eradication; Gastric lymphomatoid gastropathy; Gastric natural killer/T-cell lymphoma nasal type; Helicobacter pylori

Mesh:

Year:  2012        PMID: 22563204      PMCID: PMC3342615          DOI: 10.3748/wjg.v18.i17.2140

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Ready for prime time: NK cell priming by dendritic cells.

Authors:  Eric O Long
Journal:  Immunity       Date:  2007-04       Impact factor: 31.745

2.  Gastric involvement of extranodal NK/T-cell lymphoma, nasal type: a report of 3 cases with literature review.

Authors:  Ying-Chun Zhang; Jian-Bo Yu; Miao-Xia He; Hong-Ying Zhang; Wei-Ping Liu
Journal:  Int J Surg Pathol       Date:  2008-05-19       Impact factor: 1.271

3.  Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment.

Authors:  G E Kim; J H Cho; W I Yang; E J Chung; C O Suh; K R Park; W P Hong; I Y Park; J S Hahn; J K Roh; B S Kim
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

4.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

Authors:  T Watanabe; M Tada; H Nagai; S Sasaki; M Nakao
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

Review 5.  Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.

Authors:  Ritsuro Suzuki; Kengo Takeuchi; Koichi Ohshima; Shigeo Nakamura
Journal:  Hematol Oncol       Date:  2008-06       Impact factor: 5.271

6.  Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils.

Authors:  Mitsushige Sugimoto; Tomoyuki Ohno; David Y Graham; Yoshio Yamaoka
Journal:  Cancer Sci       Date:  2009-07-21       Impact factor: 6.716

7.  Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma.

Authors:  C-Y Chen; M Yao; J-L Tang; W Tsay; C-C Wang; W-C Chou; I-J Su; F-Y Lee; M-C Liu; H-F Tien
Journal:  Ann Oncol       Date:  2004-07       Impact factor: 32.976

Review 8.  Progress in understanding and managing natural killer-cell malignancies.

Authors:  Kazuo Oshimi
Journal:  Br J Haematol       Date:  2007-10-03       Impact factor: 6.998

9.  Primary NK-/T-cell lymphoma of the gastrointestinal tract: clinical characteristics and endoscopic findings.

Authors:  J H Kim; J H Lee; J Lee; S-O Oh; D K Chang; P-L Rhee; J J Kim; J C Rhee; J Lee; W S Kim; Y H Ko
Journal:  Endoscopy       Date:  2007-02       Impact factor: 10.093

10.  Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria.

Authors:  A Tagliabue; A D Befus; D A Clark; J Bienenstock
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  4 in total

1.  A case of lymphomatoid gastropathy: a self-limited pseudomalignant natural killer (NK)-cell proliferative disease mimicking NK/T-cell lymphomas.

Authors:  Yoko Ishibashi; Emi Matsuzono; Fumiaki Yokoyama; Yoshihito Ohara; Nozomu Sugai; Hideyuki Seki; Atsuhiko Miura; Jun Fujita; Junichi Suzuki; Takashi Fujisawa; Akira Suzuki; Yutaka Hatanaka
Journal:  Clin J Gastroenterol       Date:  2013-07-09

Review 2.  Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders.

Authors:  Susan Swee-Shan Hue; Siok-Bian Ng; Shi Wang; Soo-Yong Tan
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

3.  Lymphomatoid gastropathy/NK-cell enteropathy involving the stomach and intestine.

Authors:  Makoto Nakajima; Masayuki Shimoda; Kengo Takeuchi; Akito Dobashi; Takanori Kanai; Yae Kanai; Yasushi Iwao
Journal:  J Clin Exp Hematop       Date:  2022-04-27

4.  Lymph node involvement by enteropathy-like indolent NK-cell proliferation.

Authors:  Jean-Louis Dargent; Nicolas Tinton; Mounir Trimech; Laurence de Leval
Journal:  Virchows Arch       Date:  2020-07-21       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.